Skip to content

Clinical trials

Phase 4 Obesity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 4 Country / region: United States Clear all

198 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20036
20046
20056
200610
20076
20084
200911
201013
20118
201210
20137
20149
20152
201611
201712
20185
201910
20207
20214
20227
202311
20247
202513
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed125
Terminated22
Recruiting16
Active, not recruiting14
Withdrawn9
Not yet recruiting5
Unknown status4
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic15
Texas Tech University Health Sciences Center6
The Cleveland Clinic6
University of Pennsylvania6
Weill Medical College of Cornell University5
Beth Israel Deaconess Medical Center4
Columbia University4
The University of Texas Health Science Center, Houston4
University of Colorado, Denver4
University of Texas Southwestern Medical Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity198
Overweight31
Diabetes Mellitus, Type 222
Weight Loss22
Insulin Resistance12
Diabetes Mellitus9
Metabolic Syndrome9
Body Weight8
Prediabetic State8
Glucose Intolerance7

Trials

Showing 1 to 25 of 198. Each trial links to its page on Pharma Observatory.

98 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.